rs1064794841
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001134673.4(NFIA):c.70C>T(p.Arg24*) variant causes a stop gained change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_001134673.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NFIA | NM_001134673.4 | c.70C>T | p.Arg24* | stop_gained | Exon 2 of 11 | ENST00000403491.8 | NP_001128145.1 | |
NFIA | NM_001145512.2 | c.205C>T | p.Arg69* | stop_gained | Exon 3 of 12 | NP_001138984.1 | ||
NFIA | NM_001145511.2 | c.46C>T | p.Arg16* | stop_gained | Exon 2 of 11 | NP_001138983.1 | ||
NFIA | NM_005595.5 | c.70C>T | p.Arg24* | stop_gained | Exon 2 of 10 | NP_005586.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Brain malformations with or without urinary tract defects Pathogenic:1
Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with brain malformations with or without urinary tract defects (MIM#613735). (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0115 - Variants in this gene are known to have variable expressivity. Intra- and inter-familial variability has been observed (PMID: 28941020). (I) 0204 - Variant is predicted to result in a truncated protein (premature termination codon is located within the first 100 nucleotides of the coding sequence and is predicted to escape nonsense-mediated decay) with at least 1/3 of the protein sequence affected. (SP) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0703 - Other premature termination codon variants comparable to the one identified in this case have moderate previous evidence for pathogenicity. p.(Trp30*) and p.(Gln34*) have been classified as pathogenic by clinical laboratories in ClinVar. (SP) 0802 - This variant has moderate previous evidence of pathogenicity in unrelated individuals. This variant has been classified as pathogenic or likely pathogenic by clinical laboratories in ClinVar. This variant has also been observed in a mother and daughter and an unrelated de novo individual with NFIA-related symptoms (PMID: 28941020). (SP) 1007 - No published functional evidence has been identified for this variant. (I) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign -
Chromosome 1p32-p31 deletion syndrome Pathogenic:1
- -
not provided Pathogenic:1
The R24X variant in the NFIA gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The R24X variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The R24X variant is a strong candidate for a pathogenic variant -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at